P2000 - A high-nitrogen austenitic steel for application in bone surgery

Area of Science:

• Biomaterials Science
• Orthopedic Surgery
• Materials Engineering

Background:

• Optimal bone fracture treatment requires implant alloys with high strength and ductility.
• Current implants like TiAl6V4 titanium and 316L steel have limitations.
• Nickel-free, high-nitrogen austenitic steel P2000 (1.4452) offers high strength and superior ductility.

Purpose of the Study:

• To compare the biocompatibility and hemocompatibility of P2000 with titanium, 316L steel, and CoCrMo.
• To evaluate P2000's effects on osteoblast cell metabolism, function, and mineralization.
• To assess the electrochemical and mechanical properties of P2000 relative to existing implant materials.

Main Methods:

• Biocompatibility and hemocompatibility testing (DIN ISO 10993-5, 10993-4).
• Osteoblast assays (ALP activity, RUNX2 protein levels, Alizarin Red S staining).
• Nanoindentation hardness tests and electrochemical corrosion resistance analysis.

Main Results:

• P2000 exhibited good biocompatibility with fibroblasts and osteoblasts.
• Osteoblast function showed significantly increased ALP activity (2x) and RUNX2 levels (>4x) on P2000.
• Osteoblast biomineralization was over 6x higher on P2000 compared to titanium.
• P2000 demonstrated no hemolytic effects, good hemocompatibility, and improved corrosion resistance over 316L steel.
• P2000's hardness (5.6 GPa) was comparable to titanium (4 GPa) and lower than CoCrMo (7.5 GPa).

Conclusions:

• The nickel-free high-nitrogen steel P2000 is a promising alternative for bone implants.
• P2000 demonstrates comparable or superior biocompatibility, hemocompatibility, and mechanical properties to titanium, 316L, and CoCrMo.
• P2000 supports enhanced osteoblast activity and mineralization, suggesting improved bone healing potential.